Evaluation of risk factors for cataract types in a competing risks framework

Ophthalmic Epidemiology

Volumn 16, Issue 2, 2009, Pages 98-106

  Glynn, Robert J ^a   Rosner, Bernard ^a   Christen, William G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cataract; Competing risks; Data augmentation; Proportional hazards models; Prospective studies; Risk factors; Survival analysis

Indexed keywords

ACETYLSALICYLIC ACID; BETA CAROTENE; MULTIVITAMIN; PLACEBO;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CATARACT; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING; SURVIVAL; VISUAL ACUITY; CLASSIFICATION; COMORBIDITY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BETA CAROTENE; CARDIOVASCULAR DISEASES; CATARACT; COMORBIDITY; DOUBLE-BLIND METHOD; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PHYSICIANS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SURVIVAL ANALYSIS; UNITED STATES; VISUAL ACUITY;

EID: 65449153325     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.1080/09286580902737532     Document Type: Article

References (44)

1. World Health Organization. Magnitude and causes of visual impairment. Fact Sheet No. 282. November 2004. Accessed February 11, 2009 at www.who.int/mediacentre/factsheets/fs282/en.
2. Mohan M, Sperduto RD, Angra SK, Milton RC, Mathur RL, Underwood BA, Pandya JN, Chhabra VK, Vajpayee RB. India-US Case-Control Study of Age-Related Cataracts. India-US Case- Control Study Group. Arch Ophthalmol. 1989;107:670-676.
3. Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol. 1991;109:244-251.
4. Age-Related Eye Disease Study Group. Risk factors associated with age-related nuclear and cortical cataract: A case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5. Ophthalmology. 2001;108:1400-1408.
5. Klein BEK, Klein R, Lee KE, Meuer SM. Socioeconomic and lifestyle factors and the 10-year incidence of age-related cataract. Am J Ophthalmol. 2003;136:506-512.
6. Klein BEK, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: The Beaver Dam Eye Study. Am J Ophthalmol. 1998;126:782-790.
7. Klein BEK, Klein R, Lee KE. Incidence of age-related cataract: the Beaver Dam Eye Study. Arch Ophthalmol. 1998;116:219-225.
8. Leske MC, Wu SY, Nemesure B, Hennis A. Risk factors for incident nuclear opacities. Ophthalmology. 2002;109:1303-1308.
9. Hennis A, Wu S-Y, Nemesure B, Leske MC. Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies. Arch Ophthalmol. 2004;122:525-530.
10. Leske MC, Wu S-Y, Nemesure B, Li X, Hennis A, Connell AM. Incidence and progression of lens opacities in the Barbados Eye Studies. Ophthalmology. 2000;107:1267-1273.
11. Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol. 1986;124:916-925.
12. Hiller R, Sperduto RD, Podgor MJ, Wilson PW, Feris FL III, Colton T, D'Agostino RB, Roseman MJ, Stockman ME, Milton RC. Cigarette smoking and the risk of development of lens opacities: The Framingham Study. Arch Ophthalmol. 1997;115:1113-1118.
13. Hiller R, Podgor MJ, Sperduto RD, Nowroozi L, Wilson PWF, D'Agostino RB, Colton T. A longitudinal study of body mass index and lens opacities: The Framingham Studies. Ophthalmology. 1998;105:1244-1250.
14. Nirmalan PK, Robin AJ, Katz J, Tielsch JM, Thulasiraj RD, Krishnadas R, Ramakrishnan R. Risk factors for age related cataract in a rural population of southern India: The Aravind Comprehensive Eye Study. Br J Ophthalmol. 2004;88:989-994.
15. Cumming RG, Mitchell P. Alcohol, smoking and cataracts: The Blue Mountains Eye Study. Arch Ophthalmol. 1997;115:1296-1303.
16. Kuzniarz M, Mitchell P, Cumming RG, Flood VM. Use of vitamin supplements and cataract: The Blue Mountains Eye Study. Am J Ophthalmol.2001;132:19- 26.
17. Kuang T-M, Tsai S-Y, Hsu W-M, Cheng C-Y, Liu J-H, Chou P. Body mass index and age-related cataract: The Shihpai Eye Study. Arch Ophthalmol. 2005;123:1109-1114.
18. Leske MC, Chylack LT Jr, He Q, Wu SY, Schoenfeld E, Friend J, Wolfe J. Antioxidant vitamins and nuclear opacities: The longitudinal study of cataract. Ophthalmology.1998;105:831-836.
19. Hankinson SE, Willett WC, Colditz GA, Seddon JM, Rosner B, Speizer FE, Stampfer MJ. A prospective study of cigarette smoking and risk of cataract surgery in women. JAMA. 1992;268:994-008.
20. Weintraub JM, Willett WC, Rosner B, Colditz GA, Seddon JM, Hankinson SE. A prospective study of the relationship between body mass index and cataract extraction among women and men. Intern J Obesity. 2002;26:1588-1595.
21. Mukesh BN, Le A, Dimitrov PN, Ahmed S, Taylor HR, McCarty CA. Development of cataract and associated risk factors: The Visual Impairment Project. Arch Ophthalmol. 2006;124:79-85.
22. Sperduto RD, Hu TS, Milton RC, Zhao JL, Everett DF, Cheng QF, Blot WH, Bing L, Taylor PR, Li JY, et al. The Linxian cataract studies: Two nutrition intervention trials. Arch Ophthalmol. 1993;111:1246-1253.
23. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439-1452.
24. Christen WG, Manson JE, Seddon JM, Glynn RJ, Buring JE, Rosner B, Hennekens CH. A prospective study of cigarette smoking and risk of cataract. JAMA. 1992;268:989-993.
25. Seddon JM, Christen WG, Manson JE, LaMotte FS, Glynn RJ, Buring JE, Hennekens CH. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Pub Health. 1994;84:788-792.
26. Glynn RJ, Christen WG, Manson JE, Bernheimer J, Hennekens CH. Body mass index: An independent predictor of cataract. Arch Ophthalmol. 1995;113:1131-1137.
27. Schaumberg DA, Glynn RJ, Christen WG, Ajani UA, Stürmer T, Hennekens CH. A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol. 2001;11:104-110.
28. Christen WG, Manson JE, Glynn RJ, Gaziano JM, Sperduto RD, Buring JE, Hennekens CH. A randomized trial of beta carotene and age-related cataract in US physicians. Arch Ophthalmol. 2003;121:372-378.
29. Marshall RJ, Chisholm EM. Hypothesis testing in the polychoto- mous logistic regression model with an application to detecting gastrointestinal cancer. Stat Med. 1985;4:337-344.
30. Glynn RJ, Rosner B. Methods to evaluate risks for composite end points and their individual components. J Clin Epidemiol. 2004;57:113-122.
31. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51:524-532.
32. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke and venous thromboem- bolism. Am J Epidemiol. 2005;162:975-982.
33. Lee EW, Wei LJ, Amato DJ. Cox-type regression analysis for large numbers of small groups of correlated failure time observations. In: Klein JP, Goel PK, eds. Survival Analysis: State of the Art. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1992;237-247.
34. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Statist Assoc. 1989;84:1065-1073.
35. The Steering Committee of the Physicians' Health Study Research Group. Belanger C, Buring JE, Cook N, Eberlein K, Goldhaber SZ, Gordon D, Hennekens CH (Chairman), Mayrent SL, Peto R, Rosner B, Stampfer M, Stubblefield F, Willett W. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989;321:129-135.
36. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with beta- carotene on the incidence of malignant neoplasms and cardiovascular disease. N Eng J Med. 1996;334:1145-1149.
37. Gaynor JJ, Feuer EJ, Tan CC, Wu DH, Little CR, Straus DJ, Clarkson BD, Brennan MF. On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. J Am Statist Assoc. 1993;88:400-409.
38. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curvesin summarizing competing risks failure time data? Stat Med. 1993;12:548-555.
39. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: Choice of the time-scale. Am J Epidemiol. 1997;145:72-80.
40. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer-Verlag, 2000;44-47.
41. Rotnitzky A, Jewell NA. Hypothesis testing of regression parameters in semiparametric generalized linear models for cluster correlated data. Biometrika. 1990;77:485-497.
42. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-241.
43. Beyersmann J, Dettenkofer M, Bertz H, Shumacher M. A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards. Stat Med. 2007;26:5360-5369.
44. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389-2430.